Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA

Author： Barrou Benoît   Benoît Gérard   Ouldkaci Mahmoud   Cussenot Olivier   Salcedo Margarita   Agrawal Sudhanshu   Massicard Séverine   Bercovici Nadège   Ericson Mats   Thiounn Nicolas  

Publisher： Springer Publishing Company

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.53, Iss.5, 2004-05, pp. : 453-460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Enhanced Antitumor Effects by the Coculture of Allotumor RNA-Pulsed Dendritic Cells with Autologous Cytokine-Induced Killer Cells on Hormone-Refractory Prostate Cancer

By Pang Jun   Gao Xin   Liu Xiaopeng   Wang Kebing   Zhang Yan   Feng Lianqiang   Zhan Hailun  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 527-534

Informa Healthcare

Access to resources Recommend Favorite

The contribution of dendritic cells to immune responses against urological cancers - T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

By Troy A.   Davidson P.   Atkinson C.   Hart D.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 1, 1998-01 ,pp. : 17-23

Elsevier

Access to resources Recommend Favorite

Vaccination with p53-peptide–pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study

By Svane Inge   Pedersen Anders   Johnsen Hans   Nielsen Dorte   Kamby Claus   Gaarsdal Eva   Nikolajsen Kirsten   Buus Søren   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 633-641

Springer Publishing Company

Access to resources Recommend Favorite

Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide–pulsed dendritic cells

By Matsuda Kenji   Tsunoda Takuya   Tanaka Hajime   Umano Yasukazu   Tanimura Hiroshi   Nukaya Ikuei   Takesako Kazutoh   Yamaue Hiroki  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 609-616

Springer Publishing Company

Access to resources Recommend Favorite

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

By Svane Inge   Pedersen Anders   Johansen Julia   Johnsen Hans   Nielsen Dorte   Kamby Claus   Ottesen Svend   Balslev Eva   Gaarsdal Eva   Nikolajsen Kirsten   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 9, 2007-09 ,pp. : 1485-1499

Springer Publishing Company

Access to resources Recommend Favorite